ClinConnect ClinConnect Logo
Search / Trial NCT00653237

Laryngeal Mask Supreme™ Versus the I-gel™

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Apr 3, 2008

Trial Information

Current as of July 22, 2025

Completed

Keywords

ClinConnect Summary

The LMA Supreme™ and the I-gel™ are both new developed supraglottic airway devices to provide patent airways during general anesthesia. So far, prospective randomized controlled trials comparing their performance are not yet published. Both devices can be used in difficult airway situations, pre-hospital and in the hospital. In this prospective, randomized, controlled cross-over trial, we are going to evaluate the performance of both devices in a simulated difficult airway scenario using an extrication collar to limit both mouth opening and neck movement. In a maximum total of 60 patients u...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA 1-3 patients undergoing elective operation
  • Exclusion Criteria:
  • Not speaking german or refusing to participate
  • BMI \>35, \<50kg
  • Planned operation time \>4h
  • High risk of aspiration
  • Cervical spine disease, known difficult airway, mouth opening \<20mm
  • Upper respiratory tract symptoms in the previous 10 days
  • Preoperative sore throat
  • Poor dentition with high risk of damage

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Berne, , Switzerland

Patients applied

0 patients applied

Trial Officials

Robert Greif, M.D.

Study Director

Department of Anesthesia, University Hospital Berne, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials